Pediatr Gastroenterol Hepatol Nutr.  2019 Jan;22(1):80-85. 10.5223/pghn.2019.22.1.80.

The Characteristics and Outcomes of Abernethy Syndrome in Korean Children: A Single Center Study

• Kim ES
• Lee KW
• Choe YH

• KMID: 2430919
• DOI: http://doi.org/10.5223/pghn.2019.22.1.80

Abstract

PURPOSE
Abernethy malformation is a rare condition, which was first described in 1793 as a congenital extrahepatic porto-systemic shunt (CEPS) directing splanchnic blood flow into the inferior vena cava. Eighty cases have been published so far that reported CEPS, while in Korea, very few cases have been reported. Through this study, we present 6 cases of patients diagnosed with CEPS at Samsung Medical Center and compare these with other such cases published in France and China.
METHODS
We reviewed clinical, laboratory, and imaging data of 6 children with CEPS in our pediatric clinic between 2004 and 2017.
RESULTS
A total of 6 children with CEPS was included in this study, namely, one with type 1a, two with type 1b, and three with type 2 CEPS. The most common presenting symptom was gastrointestinal bleeding (50.0%). Therapeutic interventions included shunting vessel ligation (16.7%) in type 2 CEPS and liver transplantation (16.7%) in type 2 CEPS patient with suddenly developed hepatic encephalopathy.
CONCLUSION
There is no consensus guideline for the optimal management of patients with CEPS. Large-sample studies regarding CEPS are needed to evaluate the characteristics of patients with CEPS and determine the treatment guideline for CEPS.

Keyword

Congenital extrahepatic portosystemic shunt; Korean children

MeSH Terms

Child*
China
Consensus
France
Hemorrhage
Hepatic Encephalopathy
Humans
Korea
Ligation
Liver Transplantation
Vena Cava, Inferior

Reference

1. Kumar A, Kumar J, Aggarwal R, Srivastava S. Abernethy malformation with portal vein aneurysm. Diagn Interv Radiol. 2008; 14:143–146.

2. Burdall OC, Grammatikopoulos T, Sellars M, Hadzic N, Davenport M. Congenital vascular malformations of the liver: an association with trisomy 21. J Pediatr Gastroenterol Nutr. 2016; 63:e141–e146.

3. Niwa T, Aida N, Tachibana K, Shinkai M, Ohhama Y, Fujita K, et al. Congenital absence of the portal vein: clinical and radiologic findings. J Comput Assist Tomogr. 2002; 26:681–686.

4. Yi JE, Jung HO, Youn HJ, Choi JY, Chun HJ, Lee JY. A case of pulmonary arterial hypertension associated with congenital extrahepatic portocaval shunt. J Korean Med Sci. 2014; 29:604–608.

5. Gong Y, Zhu H, Chen J, Chen Q, Ji M, Pa M, et al. Congenital portosystemic shunts with and without gastrointestinal bleeding - case series. Pediatr Radiol. 2015; 45:1964–1971.

6. Timpanaro T, Passanisi S, Sauna A, Trombatore C, Pennisi M, Petrillo G, et al. Congenital portosystemic shunt: our experience. Case Rep Pediatr. 2015; 2015:691618.

7. Lee HJ, Lee JH, Huh J, Kang IS, Lee HJ, Suh YL, et al. A case of congenital extra hepatic portocaval shunt(abernethy malformation type 2) with a very largeliver mass and an atrial septal defect. Korean J Pediatr Gastroenterol Nutr. 2008; 11:56–59.

8. Franchi-Abella S, Branchereau S, Lambert V, Fabre M, Steimberg C, Losay J, et al. Complications of congenital portosystemic shunts in children: therapeutic options and outcomes. J Pediatr Gastroenterol Nutr. 2010; 51:322–330.

9. Scalabre A, Gorincour G, Hery G, Gamerre M, Guys JM, de Lagausie P. Evolution of congenital malformations of the umbilical-portal-hepatic venous system. J Pediatr Surg. 2012; 47:1490–1495.

10. Yazal Erdem A, Emir S, Demir HA, Özyörük D, Çetin İ, Turan A, et al. Focal nodulary hyperplasia of the liver due to congenital portosystemic shunt: a rare condition mimicking hepatocellulary carcinoma. J Pediatr Hematol Oncol. 2017; 39:e8–e10.

11. Kim MJ, Ko JS, Seo JK, Yang HR, Chang JY, Kim GB, et al. Clinical features of congenital portosystemic shunt in children. Eur J Pediatr. 2012; 171:395–400.

12. Mistinova J, Valacsai F, Varga I. Congenital absence of the portal vein--Case report and a review of literature. Clin Anat. 2010; 23:750–758.

13. Sharma R, Suddle A, Quaglia A, Peddu P, Karani J, Satyadas T, et al. Congenital extrahepatic portosystemic shunt complicated by the development of hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int. 2015; 14:552–557.

14. Kwapisz L, Wells MM, AlJudaibi B. Abernethy malformation: congenital absence of the portal vein. Can J Gastroenterol Hepatol. 2014; 28:587–588.

15. Kong Y, Zhang H, Liu C, Wu D, He X, Xiao M, et al. Abernethy malformation with multiple aneurysms: incidentally found in an adult woman with Caroli's disease. Ann Hepatol. 2013; 12:327–331.

16. Fu L, Wang Q, Wu J, Guo Y, Huang M, Liu T, et al. Congenital extrahepatic portosystemic shunt: an underdiagnosed but treatable cause of hepatopulmonary syndrome. Eur J Pediatr. 2016; 175:195–201.

17. Charre L, Roggen F, Lemaire J, Mathijs J, Goffette P, Danse E, et al. Hematochezia and congenital extrahepatic portocaval shunt with absent portal vein: successful treatment by liver transplantation. Transplantation. 2004; 78:1404–1406.

18. Pathak A, Agarwal N, Mandliya J, Gehlot P, Dhaneria M. Abernethy malformation: a case report. BMC Pediatr. 2012; 12:57.

19. Bernard O, Franchi-Abella S, Branchereau S, Pariente D, Gauthier F, Jacquemin E. Congenital portosystemic shunts in children: recognition, evaluation, and management. Semin Liver Dis. 2012; 32:273–287.

20. Zhang B, Wu KT, Li L, Lai HY. Catheter embolization of type II congenital extrahepatic portosystemic shunt with hematochezia: a case series and review of the literature. Cardiovasc Intervent Radiol. 2018; 41:1121–1127.

21. Sanada Y, Urahashi T, Ihara Y, Wakiya T, Okada N, Yamada N, et al. The role of operative intervention in management of congenital extrahepatic portosystemic shunt. Surgery. 2012; 151:404–411.